Evonik to shut smallest of its methionine plants as it concentrates production

By Jane Byrne contact

- Last updated on GMT

© GettyImages/ojogabonitoo
© GettyImages/ojogabonitoo

Related tags: methionine, Amino acid

German specialty chemicals company, Evonik, is set to manage all its DL-methionine production from three hubs in Europe, Americas and Asia to maximize economies of scale.

Evonik has been producing its DL-methionine product, branded as MetAMINO, in Wesseling since 1967. However, that facility, which has production capacity of 65,000 tons, is now set to close at the end of the first quarter of 2021. 

But the company is to strengthen its intermediates production facility, which is also located at the Wesseling site. It announced that it is investing €25m in that plant to safeguard the long-term supply of intermediates to its Antwerp, Belgium DL-methionine production site.

In 2014, Evonik opened its methionine production facility in Singapore. In 2019, the company doubled the nameplate capacity at the site, and today, it noted that Asian site is now the largest DL-methionine production complex in the world with a nameplate capacity of 300,000 tons per year of MetAMINO.

Alongside Singapore and Belgian sites, Evonik manufacturers the essential amino acid at a facility in Mobile, Alabama, US. All three plants are equipped with ‘best in class’ technology lines, and are also ready for cost efficient modular debottlenecking in the future, said the producer. 

“All three methionine hubs can be more or less easily expanded if market demands more volumes,”​ a spokesperson for Evonik told us.

With such a consolidation strategy underway, the company said it is now well placed for future growth at an improved competitive cost position.

“We will adapt to market challenges and prepare our asset set-up for highest efficiency and further optimized cost structures. We have engaged in continuous efficiency measures and programs over the past few years. As part of structural asset optimization, the time felt right to close the smallest methionine asset,”​ said Dr Emmanuel Auer, head of the animal nutrition business at Evonik.

Related news

Related products

show more

Effect of yeast nutritional factors on immune health

Effect of yeast nutritional factors on immune health

Angel Yeast Co., Ltd. | 07-Sep-2020 | Technical / White Paper

The nutritional status of animals affects their immune functions and resistance to diseases. Hence, nutrition deficiency can cause damage to the animal’s...

Stodi & Gut Immunity a Dominant Relationship

Stodi & Gut Immunity a Dominant Relationship

Natural Remedies | 11-Feb-2019 | Application Note

STODI® is a polyherbal gut-enhancing anti-diarrhoeal formulation consisting of an effective combination of ellagitannins, andrographilides, punicalgins...

Rumen acidosis in the context of precision farming

Rumen acidosis in the context of precision farming

Lallemand Animal Nutrition | 07-Nov-2018 | Technical / White Paper

Rumen acidosis is recognized by nutritionists and livestock producers as a major nutritional disorder with many consequences on cattle health and performance....

Related suppliers

Follow us

Products

View more

Webinars